These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 28059585)

  • 1. Initiation of aberrant DNA methylation patterns and heterogeneity in precancerous lesions of human hepatocellular cancer.
    Hlady RA; Zhou D; Puszyk W; Roberts LR; Liu C; Robertson KD
    Epigenetics; 2017 Mar; 12(3):215-225. PubMed ID: 28059585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenome-wide association study in hepatocellular carcinoma: Identification of stochastic epigenetic mutations through an innovative statistical approach.
    Gentilini D; Scala S; Gaudenzi G; Garagnani P; Capri M; Cescon M; Grazi GL; Bacalini MG; Pisoni S; Dicitore A; Circelli L; Santagata S; Izzo F; Di Blasio AM; Persani L; Franceschi C; Vitale G
    Oncotarget; 2017 Jun; 8(26):41890-41902. PubMed ID: 28514750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using Illumina Infinium HumanMethylation 450K BeadChip to explore genome‑wide DNA methylation profiles in a human hepatocellular carcinoma cell line.
    Sun N; Zhang J; Zhang C; Shi Y; Zhao B; Jiao A; Chen B
    Mol Med Rep; 2018 Nov; 18(5):4446-4456. PubMed ID: 30221710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas.
    Ding X; He M; Chan AWH; Song QX; Sze SC; Chen H; Man MKH; Man K; Chan SL; Lai PBS; Wang X; Wong N
    Gastroenterology; 2019 Dec; 157(6):1630-1645.e6. PubMed ID: 31560893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA Methylation Profiling of Human Hepatocarcinogenesis.
    Hernandez-Meza G; von Felden J; Gonzalez-Kozlova EE; Garcia-Lezana T; Peix J; Portela A; Craig AJ; Sayols S; Schwartz M; Losic B; Mazzaferro V; Esteller M; Llovet JM; Villanueva A
    Hepatology; 2021 Jul; 74(1):183-199. PubMed ID: 33237575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of epigenetic aberrations in the development of hepatocellular carcinoma.
    Zhang Y
    Methods Mol Biol; 2015; 1238():709-31. PubMed ID: 25421688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide DNA methylation analysis identifies candidate epigenetic markers and drivers of hepatocellular carcinoma.
    Zheng Y; Huang Q; Ding Z; Liu T; Xue C; Sang X; Gu J
    Brief Bioinform; 2018 Jan; 19(1):101-108. PubMed ID: 27760737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiregional whole-genome sequencing of hepatocellular carcinoma with nodule-in-nodule appearance reveals stepwise cancer evolution.
    Takeda H; Takai A; Kumagai K; Iguchi E; Arasawa S; Eso Y; Shimizu T; Ueda Y; Taura K; Uemoto S; Kita R; Haga H; Marusawa H; Fujimoto A; Seno H
    J Pathol; 2020 Dec; 252(4):398-410. PubMed ID: 32815153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variable Intra-Tumor Genomic Heterogeneity of Multiple Lesions in Patients With Hepatocellular Carcinoma.
    Xue R; Li R; Guo H; Guo L; Su Z; Ni X; Qi L; Zhang T; Li Q; Zhang Z; Xie XS; Bai F; Zhang N
    Gastroenterology; 2016 Apr; 150(4):998-1008. PubMed ID: 26752112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic mechanisms in hepatocellular carcinoma: how environmental factors influence the epigenome.
    Herceg Z; Paliwal A
    Mutat Res; 2011; 727(3):55-61. PubMed ID: 21514401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigating the mechanism of hepatocellular carcinoma progression by constructing genetic and epigenetic networks using NGS data identification and big database mining method.
    Li CW; Chang PY; Chen BS
    Oncotarget; 2016 Nov; 7(48):79453-79473. PubMed ID: 27821810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation Therapy by Epigenetic Reconditioning Exerts Antitumor Effects on Liver Cancer Cells.
    Gailhouste L; Liew LC; Yasukawa K; Hatada I; Tanaka Y; Nakagama H; Ochiya T
    Mol Ther; 2018 Jul; 26(7):1840-1854. PubMed ID: 29759938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic landscape of copy number aberrations enables the identification of oncogenic drivers in hepatocellular carcinoma.
    Wang K; Lim HY; Shi S; Lee J; Deng S; Xie T; Zhu Z; Wang Y; Pocalyko D; Yang WJ; Rejto PA; Mao M; Park CK; Xu J
    Hepatology; 2013 Aug; 58(2):706-17. PubMed ID: 23505090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NOXIN as a cofactor of DNA polymerase-primase complex could promote hepatocellular carcinoma.
    Zhang ZZ; Huang J; Wang YP; Cai B; Han ZG
    Int J Cancer; 2015 Aug; 137(4):765-75. PubMed ID: 25612832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonlinear tumor evolution from dysplastic nodules to hepatocellular carcinoma.
    Joung JG; Ha SY; Bae JS; Nam JY; Gwak GY; Lee HO; Son DS; Park CK; Park WY
    Oncotarget; 2017 Jan; 8(2):2076-2082. PubMed ID: 27409339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular pathogenesis of human hepatocellular carcinoma.
    Thorgeirsson SS; Grisham JW
    Nat Genet; 2002 Aug; 31(4):339-46. PubMed ID: 12149612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Epigenetic Regulation of HCC Metastasis.
    Han TS; Ban HS; Hur K; Cho HS
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30544763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulation of the epigenetic regulator SETDB1 in liver carcinogenesis-more than one way to skin a cat.
    Longerich T
    Chin Clin Oncol; 2016 Dec; 5(6):72. PubMed ID: 27164857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide DNA methylation and hydroxymethylation analysis reveal human menstrual blood-derived stem cells inhibit hepatocellular carcinoma growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements.
    Wu Y; Chen X; Zhao Y; Wang Y; Li Y; Xiang C
    Stem Cell Res Ther; 2019 May; 10(1):151. PubMed ID: 31151404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic signatures of alcohol abuse and hepatitis infection during human hepatocarcinogenesis.
    Hlady RA; Tiedemann RL; Puszyk W; Zendejas I; Roberts LR; Choi JH; Liu C; Robertson KD
    Oncotarget; 2014 Oct; 5(19):9425-43. PubMed ID: 25294808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.